360Dx

Neurological & Psychological Disorders

News on research and diagnostic developments in neuroscience.

Lund Team IDs Plasma Phosphorylated Tau as Protein Biomarker for Alzheimer's

Premium

The findings suggest blood-based testing for tau brain deposits is feasible and could be combined with other blood-based assays to improve Alzheimer's testing.

Quanterix Q4 Revenues Up 46 Percent

The company posted Q4 revenues of $15.9 million, up from $10.9 million in Q4 2018, and beat the consensus Wall Street estimate of $14.2 million.

German Dx Firm InfanDx Nabs €1M to Develop Neonatal Encephalopathy CDx

InfanDx is taking the lead on the project and will be joined by researchers from University Hospital Essen, Clinic for Pediatrics I, and Furtwangen University.

ADx Healthcare to Launch Alzheimer's Polygenic Risk Test Through Japanese Clinic

The company will offer a 32-gene polygenic score test to patients in the Osaka, Japan Nakanoshima Clinic, with reporting and patient support help from IxLayer.

Highly Sensitive, Multiplexed Alzheimer's Biosensor Takes Aim at Early Detection

Premium

A Korean research team is developing a biosensor that boosted sensitivity by using low-cost fabrication to align high-density carbon nanotubes.

Feb 19, 2020

Veravas Raises $4M in Seed Funding

Feb 11, 2020

Quest Files Motion for Summary Judgment in Wrongful Death Lawsuit

Jan 13, 2020

Alzheimer's Diagnostic Targeted by Veravas, Tymora Deal

Jan 09, 2020

Alzheimer's Researchers Propose Moving Towards Biological, Biomarker-Based Definition of Disease

Premium

Dec 18, 2019

Evogen, Mayo Validating Proteomic Epilepsy Biomarkers

Premium

Dec 11, 2019

Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

Dec 06, 2019

CDC Awards Aptagen $988K for Pork Tapeworm Test

Dec 04, 2019

Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development

Nov 25, 2019

Asuragen, Wave Life Sciences to Develop Companion Diagnostics for Huntington's Disease Therapies

Nov 21, 2019

DiamiR Wins $492K Grant for Alzheimer's Disease Dx Research

Nov 12, 2019

Quanterix Takes Step Toward Clinical Market With Siemens Licensing Deal

Premium

Nov 04, 2019

Quanterix Licenses Nf-L Antibodies to Siemens Healthineers

Oct 10, 2019

FYR Diagnostics Wins $618K NIH Grant to Develop Acquired Epilepsy Assay

Sep 26, 2019

Mental Health Advocacy Groups Appeal to FDA to Reconsider PGx Enforcement Activity

Sep 16, 2019

Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA

Sep 12, 2019

Experimental PTSD Blood-Based Diagnostic Assay Developed by NYU, US Army

Premium

Sep 10, 2019

Abbott Traumatic Brain Injury Test Boosted by New Study

Premium

Sep 05, 2019

Saladax Biomedical Gets CE Mark for Antipsychotic Drug POC Test

Aug 26, 2019

Medicortex Finland Developing Glycan Biomarker Test for Concussion

Premium

Aug 21, 2019

Quantabio Continues Newborn Screening Expansion as Tech Adopted by Wisconsin State Program

Premium